Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Wakino, S; Kintscher, U; Kim, S; Jackson, S; Yin, F; Nagpal, S; Chandraratna, RAS; Hsueh, WA; Law, RE
   Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators
   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
   
   S. Wakino et al., "Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators", ART THROM V, 21(5), 2001, pp. 746-751
2. Devereaux, PJ; Anderson, DR; Gardner, MJ; Putnam, W; Flowerdew, GJ; Brownell, BF; Nagpal, S; Cox, JL
   Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study
   BRITISH MEDICAL JOURNAL
   
   P.J. Devereaux et al., "Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study", BR MED J, 323(7323), 2001, pp. 1218-1221
3. Nagpal, S; Lu, HF; Boehm, MF
   Vitamin D analogs: Mechanism of action and therapeutic applications
   CURRENT MEDICINAL CHEMISTRY
   
   S. Nagpal et al., "Vitamin D analogs: Mechanism of action and therapeutic applications", CURR MED CH, 8(13), 2001, pp. 1661-1679
4. Campbell, NRC; Nagpal, S; Drouin, D
   Implementing hypertension recommendations
   CANADIAN JOURNAL OF CARDIOLOGY
   
   N.R.C. Campbell et al., "Implementing hypertension recommendations", CAN J CARD, 17(8), 2001, pp. 851-853
5. Campbell, NRC; Carruthers, SG; Wilson, E; Nagpal, S; Chockalingam, A; Squires, T; Levine, M; Zarnke, K; McAlister, F; Abbott, C; Mann, K; Bolli, P; McKay, D; Myers, M; Wilson, T; Honos, G; Burgess, E; Petrella, R; Touyz, R; Lewanczuk, R; Wright, J; Culleton, B; Leenen, F; Rabkin, S; Stone, J; Fodor, G; Hamet, P; Herman, R; Lebel, M; Burgess, E; Tobe, S; Feldman, RD; Irvine, J; Eady, A; Nagpai, S; Campbell, N; Milot, A; Chockalingam, A; Ebenhoeh, H; Drouin, D; Feldman, R; Repchinsky, C; Ruddy, T; Stewart, P; Tremblay, G; Wilson, E
   The 2000 Canadian hypertension recommendations: A summary
   CANADIAN JOURNAL OF CARDIOLOGY
   
   N.R.C. Campbell et al., "The 2000 Canadian hypertension recommendations: A summary", CAN J CARD, 17(5), 2001, pp. 535-538
6. Chuichulcherm, S; Nagpal, S; Peeva, L; Livingston, A
   Treatment of metal-containing wastewaters with a novel extractive membranereactor using sulfate-reducing bacteria
   JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
   
   S. Chuichulcherm et al., "Treatment of metal-containing wastewaters with a novel extractive membranereactor using sulfate-reducing bacteria", J CHEM TECH, 76(1), 2001, pp. 61-68
7. Thacher, SM; Vasudevan, J; Tsang, KY; Nagpal, S; Chandraratna, RAS
   New dermatological agents for the treatment of psoriasis
   JOURNAL OF MEDICINAL CHEMISTRY
   
   S.M. Thacher et al., "New dermatological agents for the treatment of psoriasis", J MED CHEM, 44(3), 2001, pp. 281-297
8. Nagpal, S; Ghosn, CR; Chandraratna, RAS
   Identification of nuclear receptor interacting proteins using yeast two-hybrid technology - Applications to drug discovery
   STEROID RECEPTOR METHODS: PROTOCOLS AND ASSAYS
   
   S. Nagpal et al., "Identification of nuclear receptor interacting proteins using yeast two-hybrid technology - Applications to drug discovery", METH MOL B, 176, 2001, pp. 359-376
9. Nagpal, S; Chandraratna, RAS
   Recent developments in receptor-selective retinoids
   CURRENT PHARMACEUTICAL DESIGN
   
   S. Nagpal e R.A.S. Chandraratna, "Recent developments in receptor-selective retinoids", CUR PHARM D, 6(9), 2000, pp. 919-931
10. Kephart, G; Sketris, I; MacLean, D; Kass, K; Nagpal, S
    Management of high blood cholesterol levels in Nova Scotian adults: Comparison with the NCEP II and European clinical practice guidelines
    AMERICAN JOURNAL OF MANAGED CARE
    
    G. Kephart et al., "Management of high blood cholesterol levels in Nova Scotian adults: Comparison with the NCEP II and European clinical practice guidelines", AM J M CARE, 6(9), 2000, pp. 1017-1028
11. Duvic, M; Helekar, B; Schulz, C; Cho, M; DiSepio, D; Hager, C; DiMao, D; Hazarika, P; Jackson, B; Breuer-McHam, J; Young, J; Clayman, G; Lippman, SM; Chandraratna, RAS; Robinson, NA; Deucher, A; Eckert, RL; Nagpal, S
    Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer
    CLINICAL CANCER RESEARCH
    
    M. Duvic et al., "Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer", CLIN CANC R, 6(8), 2000, pp. 3249-3259
12. Deucher, A; Nagpal, S; Chandraratna, RAS; Di Sepio, D; Robinson, NA; Dashti, SR; Eckert, RL
    The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity
    INTERNATIONAL JOURNAL OF ONCOLOGY
    
    A. Deucher et al., "The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity", INT J ONCOL, 17(6), 2000, pp. 1195-1203
13. Kintscher, U; Goetze, S; Wakino, S; Kim, S; Nagpal, S; Chandraratna, RAS; Graf, K; Fleck, E; Hsueh, WA; Law, RE
    Peroxisome proliferator-activated receptor and retinoid X receptor ligandsinhibit monocyte chemotactic protein-1-directed migration of monocytes
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    U. Kintscher et al., "Peroxisome proliferator-activated receptor and retinoid X receptor ligandsinhibit monocyte chemotactic protein-1-directed migration of monocytes", EUR J PHARM, 401(3), 2000, pp. 259-270
14. Mandokhot, A; Pal, R; Nagpal, S; Chauhan, VS; Ahlawat, S; Singh, O
    Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    
    A. Mandokhot et al., "Humoral hyporesponsiveness to a conjugate contraceptive vaccine and its bypass by diverse carriers using permissible adjuvant", CLIN EXP IM, 122(1), 2000, pp. 101-108
15. Masood, R; Nagpal, S; Zheng, T; Cai, J; Tulpule, A; Smith, DL; Gill, PS
    Kaposi sarcoma is a therapeutic target for vitamin D-3 receptor agonist
    BLOOD
    
    R. Masood et al., "Kaposi sarcoma is a therapeutic target for vitamin D-3 receptor agonist", BLOOD, 96(9), 2000, pp. 3188-3194
16. Nagpal, S; Chuichulcherm, S; Livingston, A; Peeva, L
    Ethanol utilization by sulfate-reducing bacteria: An experimental and modeling study
    BIOTECHNOLOGY AND BIOENGINEERING
    
    S. Nagpal et al., "Ethanol utilization by sulfate-reducing bacteria: An experimental and modeling study", BIOTECH BIO, 70(5), 2000, pp. 533-543
17. Nagpal, S; Chuichulcherm, S; Peeva, L; Livingston, A
    Microbial sulfate reduction in a liquid-solid fluidized bed reactor
    BIOTECHNOLOGY AND BIOENGINEERING
    
    S. Nagpal et al., "Microbial sulfate reduction in a liquid-solid fluidized bed reactor", BIOTECH BIO, 70(4), 2000, pp. 370-380
18. DiSepio, D; Chandraratna, RAS; Nagpal, S
    Novel approaches for the treatment of psoriasis
    DRUG DISCOVERY TODAY
    
    D. DiSepio et al., "Novel approaches for the treatment of psoriasis", DRUG DISC T, 4(5), 1999, pp. 222-231
19. Thacher, SM; Nagpal, S; Klein, ES; Arefieg, T; Krasinski, G; DiSepio, D; Agarwal, C; Johnson, A; Eckert, RL; Chandraratna, RAS
    Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: Divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes
    CELL GROWTH & DIFFERENTIATION
    
    S.M. Thacher et al., "Cell type and gene-specific activity of the retinoid inverse agonist AGN 193109: Divergent effects from agonist at retinoic acid receptor gamma in human keratinocytes", CELL GROWTH, 10(4), 1999, pp. 255-262
20. Nagpal, S; Benstead, T; Shumak, K; Rock, G; Brown, M; Anderson, DR
    Treatment of Guillain-Barre Syndrome: A cost-effectiveness analysis
    JOURNAL OF CLINICAL APHERESIS
    
    S. Nagpal et al., "Treatment of Guillain-Barre Syndrome: A cost-effectiveness analysis", J CLIN APH, 14(3), 1999, pp. 107-113
21. Mukherjee, SB; Aravinda, S; Gopalakrishnan, B; Nagpal, S; Salunke, DM; Shaha, C
    Secretion of glutathione S-transferase isoforms in the seminiferous tubular fluid, tissue distribution and sex steroid binding by rat GSTM1
    BIOCHEMICAL JOURNAL
    
    S.B. Mukherjee et al., "Secretion of glutathione S-transferase isoforms in the seminiferous tubular fluid, tissue distribution and sex steroid binding by rat GSTM1", BIOCHEM J, 340, 1999, pp. 309-320
22. Nagpal, S; Gupta, V; Kaur, KJ; Salunke, DM
    Structure-function analysis of tritrypticin, an antibacterial peptide of innate immune origin
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S. Nagpal et al., "Structure-function analysis of tritrypticin, an antibacterial peptide of innate immune origin", J BIOL CHEM, 274(33), 1999, pp. 23296-23304
23. Nagpal, S; Ghosn, C; DiSepio, D; Molina, Y; Sutter, M; Klein, ES; Chandraratna, RAS
    Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    S. Nagpal et al., "Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor", J BIOL CHEM, 274(32), 1999, pp. 22563-22568
24. Nagpal, S
    Food security in Hindukush Himalaya
    ECONOMIC AND POLITICAL WEEKLY
    
    S. Nagpal, "Food security in Hindukush Himalaya", ECON POLIT, 34(38), 1999, pp. 2717-2720
25. Gross, M; Anderson, DR; Nagpal, S; O'Brien, B
    Venous thromboembolism prophylaxis after total hip or knee arthroplasty: Asurvey of Canadian orthopedic surgeons
    CANADIAN JOURNAL OF SURGERY
    
    M. Gross et al., "Venous thromboembolism prophylaxis after total hip or knee arthroplasty: Asurvey of Canadian orthopedic surgeons", CAN J SURG, 42(6), 1999, pp. 457-461
26. MELLEMILOVANOVIC D; MILOVANOVIC M; NAGPAL S; SACHS G; SHIN JM
    REGIONS OF ASSOCIATION BETWEEN THE ALPHA-SUBUNIT AND THE BETA-SUBUNITOF THE GASTRIC H,K ATPASE
    The FASEB journal
    
    D. Mellemilovanovic et al., "REGIONS OF ASSOCIATION BETWEEN THE ALPHA-SUBUNIT AND THE BETA-SUBUNITOF THE GASTRIC H,K ATPASE", The FASEB journal, 12(5), 1998, pp. 5894-5894
27. GOPALAKRISHNAN B; ARAVINDA S; PAWSHE CH; TOTEY SM; NAGPAL S; SALUNKE DM; SHAHA C
    STUDIES ON GLUTATHIONE S-TRANSFERASES IMPORTANT FOR SPERM FUNCTION - EVIDENCE OF CATALYTIC ACTIVITY-INDEPENDENT FUNCTIONS
    Biochemical journal
    
    B. Gopalakrishnan et al., "STUDIES ON GLUTATHIONE S-TRANSFERASES IMPORTANT FOR SPERM FUNCTION - EVIDENCE OF CATALYTIC ACTIVITY-INDEPENDENT FUNCTIONS", Biochemical journal, 329, 1998, pp. 231-241
28. DiSepio, D; Ghosn, C; Eckert, RL; Deucher, A; Robinson, N; Duvic, M; Chandraratna, RAS; Nagpal, S
    Identification and characterization of a retinoid-induced class II tumor suppressor growth regulatory gene
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    D. DiSepio et al., "Identification and characterization of a retinoid-induced class II tumor suppressor growth regulatory gene", P NAS US, 95(25), 1998, pp. 14811-14815
29. MELLEMILOVANOVIC D; MILOVANOVIC M; NAGPAL S; SACHS G; SHIN JM
    REGIONS OF ASSOCIATION BETWEEN THE ALPHA-SUBUNIT AND THE BETA-SUBUNITOF THE GASTRIC H,K-ATPASE
    The Journal of biological chemistry
    
    D. Mellemilovanovic et al., "REGIONS OF ASSOCIATION BETWEEN THE ALPHA-SUBUNIT AND THE BETA-SUBUNITOF THE GASTRIC H,K-ATPASE", The Journal of biological chemistry, 273(18), 1998, pp. 11075-11081
30. NAGPAL S; CAI J; ZHENG T; PATEL S; MASOOD R; LIN GY; FRIANT S; JOHNSON A; SMITH DL; CHANDRARATNA RAS; GILL PS
    RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA
    Molecular and cellular biology
    
    S. Nagpal et al., "RETINOID ANTAGONISM OF NF-IL6 - INSIGHT INTO THE MECHANISM OF ANTIPROLIFERATIVE EFFECTS OF RETINOIDS IN KAPOSIS-SARCOMA", Molecular and cellular biology, 17(7), 1997, pp. 4159-4168
31. DUVIC M; NAGPAL S; ASANO AT; CHANDRARATNA RAS
    MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS
    Journal of the American Academy of Dermatology
    
    M. Duvic et al., "MOLECULAR MECHANISMS OF TAZAROTENE ACTION IN PSORIASIS", Journal of the American Academy of Dermatology, 37(2), 1997, pp. 18-24
32. NAGPAL S; BHATNAGAR PK
    ESTIMATION OF INCUBATION-TIME FOR THE ERASURE PROCESS IN PHASE-CHANGEMATERIALS FOR OPTICAL MEMORIES
    Physica status solidi. a, Applied research
    
    S. Nagpal e P.K. Bhatnagar, "ESTIMATION OF INCUBATION-TIME FOR THE ERASURE PROCESS IN PHASE-CHANGEMATERIALS FOR OPTICAL MEMORIES", Physica status solidi. a, Applied research, 161(1), 1997, pp. 59-64
33. CHAVALI GB; NAGPAL S; MAJUMDAR SS; SINGH O; SALUNKE DM
    HELIX-LOOP-HELIX MOTIF IN GNRH ASSOCIATED PEPTIDE IS CRITICAL FOR NEGATIVE REGULATION OF PROLACTIN SECRETION
    Journal of Molecular Biology
    
    G.B. Chavali et al., "HELIX-LOOP-HELIX MOTIF IN GNRH ASSOCIATED PEPTIDE IS CRITICAL FOR NEGATIVE REGULATION OF PROLACTIN SECRETION", Journal of Molecular Biology, 272(5), 1997, pp. 731-740
34. NAGPAL S; PATEL S; JACOBE H; DISEPIO D; GHOSN C; MALHOTRA M; TENG M; DUVIC M; CHANDRARATNA RAS
    TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TAZAROTENE-INDUCED-GENE-2 (TIG2), A NOVEL RETINOID-RESPONSIVE GENE INSKIN", Journal of investigative dermatology, 109(1), 1997, pp. 91-95
35. HAZARIKA P; DUONG DMT; HAGER C; HAKINZADEH M; SARRIS A; NAGPAL S; THACHER S; CHANDRARATNA RAS; DUVIC M
    INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES
    Journal of investigative dermatology
    
    P. Hazarika et al., "INTERFERON-INDUCIBLE PROTEIN-10 IS REDUCED BY TREATMENT WITH RAR SPECIFIC RETINOIDS IN PSORIASIS AND KERATINOCYTE CULTURES", Journal of investigative dermatology, 108(4), 1997, pp. 204-204
36. NAGPAL S; GHOSN C; DISEPIO D; MALHOTRA M; PATEL S; JACOBE H; HAGER C; THACHER S; DUVIC M; CHANDRARATNA RAS
    TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION
    Journal of investigative dermatology
    
    S. Nagpal et al., "TAZAROTENE AN RAR SELECTIVE RETINOID, AFFECTS THE EXPRESSION OF GENESASSOCIATED WITH ABNORMAL DIFFERENTIATION, HYPERPROLIFERATION AND INFLAMMATION", Journal of investigative dermatology, 108(4), 1997, pp. 245-245
37. DISEPIO D; MALHOTRA M; CHANDRARATNA RAS; NAGPAL S
    RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION
    Journal of investigative dermatology
    
    D. Disepio et al., "RETINOID INHIBITION OF MRP-8 VIA ANTAGONISM OF NF-IL6 ENHANCER ACTIVITY - A NOVEL MECHANISM OF GENE-REGULATION", Journal of investigative dermatology, 108(4), 1997, pp. 246-246
38. THACHER SM; KRASINSKI G; KLEIN ES; JOHNSON AT; NAGPAL S; CHANDRARATNA AS
    DISTINCT PATHWAYS OF RETINOID AGONIST AND INVERSE AGONIST ACTIVITY INKERATINOCYTES
    Journal of investigative dermatology
    
    S.M. Thacher et al., "DISTINCT PATHWAYS OF RETINOID AGONIST AND INVERSE AGONIST ACTIVITY INKERATINOCYTES", Journal of investigative dermatology, 108(4), 1997, pp. 248-248
39. KLEIN ES; PINO ME; JOHNSON AT; NAGPAL S; THACHER S; KRASINSKI G; CHANDRARATNA RAS
    IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS
    Journal of investigative dermatology
    
    E.S. Klein et al., "IDENTIFICATION OF RETINOIC ACID RECEPTOR INVERSE AGONISTS AND THEIR POTENTIAL USE AS THERAPEUTIC AGENTS", Journal of investigative dermatology, 108(4), 1997, pp. 249-249
40. NAGPAL S; DISEPIO D; MALHOTRA M; GHOSN C; DUVIC M; CHANDRARATNA RAS
    ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS
    Journal of investigative dermatology
    
    S. Nagpal et al., "ANTAGONISM OF TRANSCRIPTION FACTOR ACTION - A MAJOR-MODE OF THERAPEUTIC ACTION OF RETINOIDS", Journal of investigative dermatology, 108(4), 1997, pp. 297-297
41. HAGER C; DIMAIO D; MAYS S; ANGEL T; CUNNINGHAM MA; LEDBETTER L; SEFTON J; THACHER SM; NAGPAL S; CHANDRARATNA RAS; DUVIC M
    TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES
    Journal of investigative dermatology
    
    C. Hager et al., "TAZAROTENE 0.1-PERCENT GEL IS ASSOCIATED WITH ALTERATIONS IN MARKERS OF EPIDERMAL DIFFERENTIATION AND INFLAMMATION IN PSORIATIC PLAQUES", Journal of investigative dermatology, 108(4), 1997, pp. 712-712
42. DISEPIO D; MALHOTRA M; CHANDRARATNA RAS; NAGPAL S
    RETINOIC ACID RECEPTOR-NUCLEAR FACTOR-INTERLEUKIN-6 ANTAGONISM - A NOVEL MECHANISM OF RETINOID-DEPENDENT INHIBITION OF A KERATINOCYTE HYPERPROLIFERATIVE DIFFERENTIATION MARKER
    The Journal of biological chemistry
    
    D. Disepio et al., "RETINOIC ACID RECEPTOR-NUCLEAR FACTOR-INTERLEUKIN-6 ANTAGONISM - A NOVEL MECHANISM OF RETINOID-DEPENDENT INHIBITION OF A KERATINOCYTE HYPERPROLIFERATIVE DIFFERENTIATION MARKER", The Journal of biological chemistry, 272(41), 1997, pp. 25555-25559
43. NAGPAL S
    A STRUCTURED MODEL FOR THIOBACILLUS-FERROOXIDANS GROWTH ON FERROUS IRON
    Biotechnology and bioengineering
    
    S. Nagpal, "A STRUCTURED MODEL FOR THIOBACILLUS-FERROOXIDANS GROWTH ON FERROUS IRON", Biotechnology and bioengineering, 53(3), 1997, pp. 310-319
44. GREWAL N; NAGPAL S; CHAVALI GB; MAJUMDAR SS; PAL R; SALUNKE DM
    LIGAND-INDUCED RECEPTOR DIMERIZATION MAY BE CRITICAL FOR SIGNAL-TRANSDUCTION BY CHORIOGONADOTROPIN
    Biophysical journal
    
    N. Grewal et al., "LIGAND-INDUCED RECEPTOR DIMERIZATION MAY BE CRITICAL FOR SIGNAL-TRANSDUCTION BY CHORIOGONADOTROPIN", Biophysical journal, 73(3), 1997, pp. 1190-1197
45. AGARWAL C; CHANDRARATNA RAS; TENG M; NAGPAL S; RORKE EA; ECKERT RL
    DIFFERENTIAL REGULATION OF HUMAN ECTOCERVICAL EPITHELIAL-CELL LINE PROLIFERATION AND DIFFERENTIATION BY RETINOID-X-RECEPTOR-SPECIFIC AND RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS
    Cell growth & differentiation
    
    C. Agarwal et al., "DIFFERENTIAL REGULATION OF HUMAN ECTOCERVICAL EPITHELIAL-CELL LINE PROLIFERATION AND DIFFERENTIATION BY RETINOID-X-RECEPTOR-SPECIFIC AND RETINOIC ACID RECEPTOR-SPECIFIC RETINOIDS", Cell growth & differentiation, 7(4), 1996, pp. 521-530
46. NAGPAL S; THACHER SM; PATEL S; FRIANT S; MALHOTRA M; SHAFER J; KRASINSKI G; ASANO AT; TENG M; DUVIC M; CHANDRARATNA RAS
    NEGATIVE REGULATION OF 2 HYPERPROLIFERATIVE KERATINOCYTE DIFFERENTIATION MARKERS BY A RETINOIC ACID RECEPTOR-SPECIFIC RETINOID - INSIGHT INTO THE MECHANISM OF RETINOID ACTION IN PSORIASIS
    Cell growth & differentiation
    
    S. Nagpal et al., "NEGATIVE REGULATION OF 2 HYPERPROLIFERATIVE KERATINOCYTE DIFFERENTIATION MARKERS BY A RETINOIC ACID RECEPTOR-SPECIFIC RETINOID - INSIGHT INTO THE MECHANISM OF RETINOID ACTION IN PSORIASIS", Cell growth & differentiation, 7(12), 1996, pp. 1783-1791
47. NAGPAL S; PATEL S; ASANO AT; JOHNSON A; DUVIC M; CHANDRARATNA RAS
    TIG1 AND TIG2 (TAZAROTENE INDUCED GENE-1 AND GENE-2) ARE NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENES IN SKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TIG1 AND TIG2 (TAZAROTENE INDUCED GENE-1 AND GENE-2) ARE NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENES IN SKIN", Journal of investigative dermatology, 106(4), 1996, pp. 78-78
48. THACHER SM; KRASINSKI G; MALHOTRA M; DUVIC M; NAGPAL S; CHANDRARATNA RAS
    COORDINATE REGULATION OF KERATINOCYTE DIFFERENTIATION MARKERS BY RETINOIDS IN CELL-CULTURE AND IN PSORIASIS
    Journal of investigative dermatology
    
    S.M. Thacher et al., "COORDINATE REGULATION OF KERATINOCYTE DIFFERENTIATION MARKERS BY RETINOIDS IN CELL-CULTURE AND IN PSORIASIS", Journal of investigative dermatology, 106(4), 1996, pp. 82-82
49. DISEPIO D; DUVIC M; CHANDRARATNA AS; NAGPAL S
    ISOLATION OF RAR-RESPONSIVE EPIDERMAL GENES BY LONG-RANGE DIFFERENTIAL DISPLAY-PCR
    Journal of investigative dermatology
    
    D. Disepio et al., "ISOLATION OF RAR-RESPONSIVE EPIDERMAL GENES BY LONG-RANGE DIFFERENTIAL DISPLAY-PCR", Journal of investigative dermatology, 106(4), 1996, pp. 577-577
50. NAGPAL S; PATEL S; ASANO AT; JOHNSON AT; DUVIC M; CHANDRARATNA RAS
    TAZAROTENE-INDUCED GENE-1 (TIG1), A NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENE IN SKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TAZAROTENE-INDUCED GENE-1 (TIG1), A NOVEL RETINOIC ACID RECEPTOR-RESPONSIVE GENE IN SKIN", Journal of investigative dermatology, 106(2), 1996, pp. 269-274
51. KLEIN ES; PINO ME; JOHNSON AT; DAVIES PJA; NAGPAL S; THACHER SM; KRASINSKI G; CHANDRARATNA AS
    IDENTIFICATION AND FUNCTIONAL SEPARATION OF RETINOIC ACID RECEPTOR NEUTRAL ANTAGONISTS AND INVERSE AGONISTS
    The Journal of biological chemistry
    
    E.S. Klein et al., "IDENTIFICATION AND FUNCTIONAL SEPARATION OF RETINOIC ACID RECEPTOR NEUTRAL ANTAGONISTS AND INVERSE AGONISTS", The Journal of biological chemistry, 271(37), 1996, pp. 22692-22696
52. CHANDRARATNA RAS; HENRY E; ATTARD J; GILLETT SJ; SONG T; GARST ME; NAGPAL S; ATHANIKAR J; AREFIEG T; GIL DW; WHEELER LA; LEWKAYA D; SEFTON J
    DEVELOPMENT OF RAR SUBTYPE-SELECTIVE RETINOIDS FOR DERMATOLOGICAL DISEASES
    European journal of medicinal chemistry
    
    R.A.S. Chandraratna et al., "DEVELOPMENT OF RAR SUBTYPE-SELECTIVE RETINOIDS FOR DERMATOLOGICAL DISEASES", European journal of medicinal chemistry, 30, 1995, pp. 505-517
53. SCHOENFELD CL; NAGPAL S; CHANDRARATNA R; HACKETT SF; CAMPOCHIARO PA
    RETINOID RECEPTORS IN RPE - IMPLICATION OF ANTAGONISM OF AP-1 IN GROWTH-INHIBITING EFFECTS
    Investigative ophthalmology & visual science
    
    C.L. Schoenfeld et al., "RETINOID RECEPTORS IN RPE - IMPLICATION OF ANTAGONISM OF AP-1 IN GROWTH-INHIBITING EFFECTS", Investigative ophthalmology & visual science, 36(4), 1995, pp. 98-98
54. NAGPAL S; OSTROVE JM
    CHARACTERIZATION OF A POTENT VARICELLA-ZOSTER VIRUS-ENCODED TRANS-REPRESSOR (VOL 65, PG 5289, 1991)
    Journal of virology
    
    S. Nagpal e J.M. Ostrove, "CHARACTERIZATION OF A POTENT VARICELLA-ZOSTER VIRUS-ENCODED TRANS-REPRESSOR (VOL 65, PG 5289, 1991)", Journal of virology, 69(4), 1995, pp. 2723-2723
55. THACHER SM; FRIANT S; PATEL S; TENG M; CHANDRARATNA RAS; NAGPAL S
    RETINOIDS BLOCK INDUCTION OF MRP8 DURING CULTURED KERATINOCYTE DIFFERENTIATION
    Journal of investigative dermatology
    
    S.M. Thacher et al., "RETINOIDS BLOCK INDUCTION OF MRP8 DURING CULTURED KERATINOCYTE DIFFERENTIATION", Journal of investigative dermatology, 104(4), 1995, pp. 594-594
56. CHANDRARATNA RAS; STANDEVEN A; PATEL S; SHAFER J; FRIANT S; BEARD RL; THACHER S; NAGPAL S
    DIFFERENTIAL REGULATION OF AP1-DEPENDENT GENE-EXPRESSION BY RXRS IN-VITRO AND IN-VIVO
    Journal of investigative dermatology
    
    R.A.S. Chandraratna et al., "DIFFERENTIAL REGULATION OF AP1-DEPENDENT GENE-EXPRESSION BY RXRS IN-VITRO AND IN-VIVO", Journal of investigative dermatology, 104(4), 1995, pp. 594-594
57. NAGPAL S; PATEL S; ARANO AT; JOHNSON A; DUVIC M; CHANDRARATNA RAS
    TIG1 (TAZAROTENE INDUCED GENE-1), A NOVEL RAR-RESPONSIVE GENE IN SKIN
    Journal of investigative dermatology
    
    S. Nagpal et al., "TIG1 (TAZAROTENE INDUCED GENE-1), A NOVEL RAR-RESPONSIVE GENE IN SKIN", Journal of investigative dermatology, 104(4), 1995, pp. 595-595
58. ASANO AT; NAGPAL S; CHANDRARATNA RAS; DUVIC M
    TAZAROTENE (AGN-190168), A TOPICAL RETINOID, IMPROVES PSORIASIS AND ALTERS EPIDERMAL GENE-EXPRESSION
    Journal of investigative dermatology
    
    A.T. Asano et al., "TAZAROTENE (AGN-190168), A TOPICAL RETINOID, IMPROVES PSORIASIS AND ALTERS EPIDERMAL GENE-EXPRESSION", Journal of investigative dermatology, 104(4), 1995, pp. 694-694
59. NAGPAL S; ATHANIKAR J; CHANDRARATNA RAS
    SEPARATION OF TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA
    The Journal of biological chemistry
    
    S. Nagpal et al., "SEPARATION OF TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA", The Journal of biological chemistry, 270(2), 1995, pp. 923-927
60. MASOOD R; FRIANT S; CAI J; NAGPAL S; GILL P
    ANTIPROLIFERATIVE EFFECTS OF 1,25-DIHYDROXYVITAMIN-D-3 ON KAPOSIS-SARCOMA CELLS BY INHIBITING IL-6 AND IL-8 EXPRESSION
    Blood
    
    R. Masood et al., "ANTIPROLIFERATIVE EFFECTS OF 1,25-DIHYDROXYVITAMIN-D-3 ON KAPOSIS-SARCOMA CELLS BY INHIBITING IL-6 AND IL-8 EXPRESSION", Blood, 86(10), 1995, pp. 1517-1517
61. ATHANIKAR J; CHANDRARATNA R; NAGPAL S
    SEPARATION OF RETINOID-DEPENDENT TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA
    The FASEB journal
    
    J. Athanikar et al., "SEPARATION OF RETINOID-DEPENDENT TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA", The FASEB journal, 8(4), 1994, pp. 10000386-10000386
62. LIE JT; NAGPAL S
    CHURG-STRAUSS-SYNDROME WITH NONGIANT CELL EOSINOPHILIC TEMPORAL ARTERITIS
    Journal of rheumatology
    
    J.T. Lie e S. Nagpal, "CHURG-STRAUSS-SYNDROME WITH NONGIANT CELL EOSINOPHILIC TEMPORAL ARTERITIS", Journal of rheumatology, 21(2), 1994, pp. 366-367
63. BOATRIGHT JH; BORST DE; NAGPAL S; RAM H; NICKERSON JM
    CHARACTERIZATION OF TRANS-ACTING FACTORS AND CIS-ACTING ELEMENTS IN THE IRBP GENE
    Investigative ophthalmology & visual science
    
    J.H. Boatright et al., "CHARACTERIZATION OF TRANS-ACTING FACTORS AND CIS-ACTING ELEMENTS IN THE IRBP GENE", Investigative ophthalmology & visual science, 35(4), 1994, pp. 1578-1578
64. NAGPAL S; ATHANIKAR J; CHANDRARATNA R
    SEPARATION OF RETINOID-DEPENDENT TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA
    Journal of investigative dermatology
    
    S. Nagpal et al., "SEPARATION OF RETINOID-DEPENDENT TRANSACTIVATION AND AP1 ANTAGONISM FUNCTIONS OF RETINOIC ACID RECEPTOR-ALPHA", Journal of investigative dermatology, 102(4), 1994, pp. 553-553
65. CHANDARATNA R; PATEL S; DUVIC M; NAGPAL S
    SUBTRACTIVE HYBRIDIZATION CLONING OF A CANDIDATE MARKER GENE FROM SKIN RAFT CULTURES REVEALS THE ANTIINFLAMMATORY ACTION OF RETINOIDS
    Journal of investigative dermatology
    
    R. Chandaratna et al., "SUBTRACTIVE HYBRIDIZATION CLONING OF A CANDIDATE MARKER GENE FROM SKIN RAFT CULTURES REVEALS THE ANTIINFLAMMATORY ACTION OF RETINOIDS", Journal of investigative dermatology, 102(4), 1994, pp. 625-625
66. BHADRIRAJU S; AHMAD S; NAGPAL S; SMITH SJ
    PROCEDURAL UTILIZATION IN ACUTE MYOCARDIAL-INFARCTION
    Clinical research
    
    S. Bhadriraju et al., "PROCEDURAL UTILIZATION IN ACUTE MYOCARDIAL-INFARCTION", Clinical research, 42(3), 1994, pp. 10000440-10000440
67. NAGPAL S; DAHLSTROM D; OOLMAN T
    A MATHEMATICAL-MODEL FOR THE BACTERIAL OXIDATION OF A SULFIDE ORE CONCENTRATE
    Biotechnology and bioengineering
    
    S. Nagpal et al., "A MATHEMATICAL-MODEL FOR THE BACTERIAL OXIDATION OF A SULFIDE ORE CONCENTRATE", Biotechnology and bioengineering, 43(5), 1994, pp. 357-364
68. NAGPAL S; FRIANT S; NAKSHATRI H; CHAMBON P
    RARS AND RXRS - EVIDENCE FOR 2 AUTONOMOUS TRANSACTIVATION FUNCTIONS (AF-1 AND AF-2) AND HETERODIMERIZATION INVIVO
    EMBO journal
    
    S. Nagpal et al., "RARS AND RXRS - EVIDENCE FOR 2 AUTONOMOUS TRANSACTIVATION FUNCTIONS (AF-1 AND AF-2) AND HETERODIMERIZATION INVIVO", EMBO journal, 12(6), 1993, pp. 2349-2360
69. SANE AS; CHOKSHI SA; MISHRA VV; BARAD DP; SHAH VC; NAGPAL S
    SERUM LIPOPEROXIDE LEVELS IN SURGICAL STRESS OF ABDOMINAL HYSTERECTOMY
    Panminerva Medica
    
    A.S. Sane et al., "SERUM LIPOPEROXIDE LEVELS IN SURGICAL STRESS OF ABDOMINAL HYSTERECTOMY", Panminerva Medica, 35(3), 1993, pp. 131-133
70. SHANTI KN; MARTIN BM; NAGPAL S; METCALFE DD; RAO PVS
    IDENTIFICATION OF TROPOMYOSIN AS THE MAJOR SHRIMP ALLERGEN AND CHARACTERIZATION OF ITS IGE-BINDING EPITOPES
    The Journal of immunology
    
    K.N. Shanti et al., "IDENTIFICATION OF TROPOMYOSIN AS THE MAJOR SHRIMP ALLERGEN AND CHARACTERIZATION OF ITS IGE-BINDING EPITOPES", The Journal of immunology, 151(10), 1993, pp. 5354-5363
71. NAGPAL S; ZELENT A; CHAMBON P
    RAR-BETA-4, A RETINOIC ACID RECEPTOR ISOFORM IS GENERATED FROM RAR-BETA-2 BY ALTERNATIVE SPLICING AND USAGE OF A CUG INITIATOR CODON
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    S. Nagpal et al., "RAR-BETA-4, A RETINOIC ACID RECEPTOR ISOFORM IS GENERATED FROM RAR-BETA-2 BY ALTERNATIVE SPLICING AND USAGE OF A CUG INITIATOR CODON", Proceedings of the National Academy of Sciences of the United Statesof America, 89(7), 1992, pp. 2718-2722